Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8,614 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Involvement of sphingolipids in apoptin-induced cell killing.
Liu X, Zeidan YH, Elojeimy S, Holman DH, El-Zawahry AM, Guo GW, Bielawska A, Bielawski J, Szulc Z, Rubinchik S, Dong JY, Keane TE, Tavassoli M, Hannun YA, Norris JS. Liu X, et al. Mol Ther. 2006 Nov;14(5):627-36. doi: 10.1016/j.ymthe.2006.07.001. Epub 2006 Aug 22. Mol Ther. 2006. PMID: 16926120
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer.
Sudarshan S, Holman DH, Hyer ML, Voelkel-Johnson C, Dong JY, Norris JS. Sudarshan S, et al. Cancer Gene Ther. 2005 Jan;12(1):12-8. doi: 10.1038/sj.cgt.7700746. Cancer Gene Ther. 2005. PMID: 15514684
Acid ceramidase inhibition: a novel target for cancer therapy.
Liu X, Elojeimy S, Turner LS, Mahdy AE, Zeidan YH, Bielawska A, Bielawski J, Dong JY, El-Zawahry AM, Guo GW, Hannun YA, Holman DH, Rubinchik S, Szulc Z, Keane TE, Tavassoli M, Norris JS. Liu X, et al. Front Biosci. 2008 Jan 1;13:2293-8. doi: 10.2741/2843. Front Biosci. 2008. PMID: 17981711 Review.
Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.
Elojeimy S, Liu X, McKillop JC, El-Zawahry AM, Holman DH, Cheng JY, Meacham WD, Mahdy AE, Saad AF, Turner LS, Cheng J, A Day T, Dong JY, Bielawska A, Hannun YA, Norris JS. Elojeimy S, et al. Mol Ther. 2007 Jul;15(7):1259-63. doi: 10.1038/ Epub 2007 Apr 10. Mol Ther. 2007. PMID: 17426710
Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer.
Yan Y, Rubinchik S, Wood AL, Gillanders WE, Dong JY, Watson DK, Cole DJ. Yan Y, et al. Mol Ther. 2006 Feb;13(2):357-65. doi: 10.1016/j.ymthe.2005.06.485. Epub 2005 Oct 13. Mol Ther. 2006. PMID: 16226492
Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.
Yan Y, Rubinchik S, Watson PM, Kelley JR, Fraser MM, Wood AL, Dong JY, Gillanders WE, Boylan AM, Watson DK, Cole DJ. Yan Y, et al. Mol Ther. 2005 Mar;11(3):363-72. doi: 10.1016/j.ymthe.2004.09.023. Mol Ther. 2005. PMID: 15727932
Improving the transcriptional regulation of genes delivered by adenovirus vectors.
Rubinchik S, Woraratanadharm J, Schepp J, Dong JY. Rubinchik S, et al. Methods Mol Med. 2003;76:167-99. doi: 10.1385/1-59259-304-6:167. Methods Mol Med. 2003. PMID: 12526164 No abstract available.
8,614 results
Jump to page